Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther Blessing, Maria M. Steenkamp, Jorge Manzanares, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 825-836
Open Access | Times Cited: 583
50 years of hurdles and hope in anxiolytic drug discovery
Guy Griebel, Andrew Holmes
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 9, pp. 667-687
Open Access | Times Cited: 401
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar, Moran Shalev-Benami, Michael J. Robertson, et al.
Cell (2019) Vol. 176, Iss. 3, pp. 448-458.e12
Open Access | Times Cited: 398
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 220
Amygdala FAAH and anandamide: mediating protection and recovery from stress
Ozge Gunduz‐Cinar, Matthew N. Hill, Bruce S. McEwen, et al.
Trends in Pharmacological Sciences (2013) Vol. 34, Iss. 11, pp. 637-644
Open Access | Times Cited: 209
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171
The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Sari Goldstein Ferber, Dvora Namdar, Danielle Hen-Shoval, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 2, pp. 87-96
Open Access | Times Cited: 171
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
Antonio Del Casale, Serena Sorice, Alessio Padovano, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 8, pp. 710-736
Open Access | Times Cited: 165
The Polypharmacological Effects of Cannabidiol
Jorge Iván Castillo-Arellano, Ana Canseco-Alba, Stephen J. Cutler, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3271-3271
Open Access | Times Cited: 69
Emerging drugs for the treatment of anxiety
James W. Murrough, Sahab Yaqubi, Sehrish Sayed, et al.
Expert Opinion on Emerging Drugs (2015) Vol. 20, Iss. 3, pp. 393-406
Open Access | Times Cited: 153
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
The endocannabinoid system: An emotional buffer in the modulation of memory function
Maria Morena, Patrizia Campolongo
Neurobiology of Learning and Memory (2014) Vol. 112, pp. 30-43
Closed Access | Times Cited: 139
Endocannabinoid system, stress and HPA axis
Vincenzo Micale, Filippo Drago
European Journal of Pharmacology (2018) Vol. 834, pp. 230-239
Closed Access | Times Cited: 137
Cannabidiol in medical marijuana: Research vistas and potential opportunities
Carola Rong, Yena Lee, Nicole E. Carmona, et al.
Pharmacological Research (2017) Vol. 121, pp. 213-218
Closed Access | Times Cited: 129
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
G Grabner, Robert Zimmermann, Rudolf Schicho, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 35-46
Open Access | Times Cited: 121
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease
Marja D. Sepers, Lynn A. Raymond
Drug Discovery Today (2014) Vol. 19, Iss. 7, pp. 990-996
Closed Access | Times Cited: 110
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
Alvaro Llorente‐Berzal, Ana Luisa B. Terzian, Vincenzo Di Marzo, et al.
Psychopharmacology (2015) Vol. 232, Iss. 15, pp. 2811-2825
Closed Access | Times Cited: 97
Rodent models of impaired fear extinction
Nicolas Singewald, Andrew Holmes
Psychopharmacology (2018) Vol. 236, Iss. 1, pp. 21-32
Open Access | Times Cited: 89
Brain activity of anandamide: a rewarding bliss?
María Scherma, Paolo Masia, Valentina Satta, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 309-323
Open Access | Times Cited: 86
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 98, pp. 104-116
Closed Access | Times Cited: 76
Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
Camren G. Heider, Sasha A. Itenberg, Jiajia Rao, et al.
Biology (2022) Vol. 11, Iss. 6, pp. 817-817
Open Access | Times Cited: 62
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Ahmed Hasbi, Bertha K. Madras, Susan R. George
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 37
Current Challenges and Opportunities for Improved Cannabidiol Solubility
Khondker R. Hossain, Amani Alghalayini, Stella M. Valenzuela
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14514-14514
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top